Evaluation of positron emission tomography imaging to detect lymph node metastases in patients with high‐risk cutaneous squamous cell carcinoma
Authors:
- 6 April 2016
- journal article
- research article
- Published by Wiley in The Journal of Dermatology
- Vol. 43 (11) , 1314-1320
Abstract
Ten to twenty percent of high‐risk cutaneous squamous cell carcinoma (cSCC) can metastasize to regional lymph nodes. Detection of nodal metastasis is mandatory to manage high‐risk cSCC. This study was aimed to evaluate the 18F‐fluorodeoxyglucose positron emission tomography (FDG‐PET) imaging to assess lymph node (LN) metastasis of high‐risk cSCC patients. Twenty‐six patients with histologically proven primary cSCC were enrolled. All patients underwent whole‐body PET prior to lymphoscintigraphy and subsequent sentinel LN biopsy. The maximum standardized uptake value (SUVmax) of more than 2.5 is generally evaluated as a positive PET finding indicative of malignancy. On the basis of the histopathological and PET findings, 30 LN from 26 patients were categorized into four groups: (i) histologically negative and PET negative (true‐negative; n = 22); (ii) histologically positive and PET negative (false‐negative; n = 0); (iii) histologically positive and PET positive (true‐positive; n = 3); and (iv) histologically negative and PET positive (false‐positive; n = 5). The mean SUVmax was significantly higher in the true‐positive cases (11.0 ± 2.8) than in the false‐positive cases (3.4 ± 0.6). In the false‐positive cases, the number of tumor‐infiltrating inflammatory cells at the primary skin site was highest among the four groups, suggesting that inflammation contributed to the false‐positive uptake of FDG. Although we cannot negate the possibility of the presence of PET‐undetectable micrometastasis, the SUVmax value may be useful for avoidance of excess performance of sentinel LN biopsy.Keywords
Funding Information
- Japan Society for the Promotion of Science (24591625)
This publication has 22 references indexed in Scilit:
- Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma: clinical experience and review of literatureWorld Journal of Surgical Oncology, 2011
- A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: Creation and rationale for inclusion of tumor (T) characteristicsJournal of the American Academy of Dermatology, 2011
- The New Seventh Edition American Joint Committee on Cancer Staging of Cutaneous Non-Melanoma Skin CancerAmerican Journal of Clinical Dermatology, 2011
- Practical Concerns Regarding the 7th Edition AJCC Staging GuidelinesJournal of Skin Cancer, 2010
- Sentinel lymph node detection in skin cancer patients using real-time fluorescence navigation with indocyanine green: preliminary experienceJournal of Plastic, Reconstructive & Aesthetic Surgery, 2009
- Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanomaMelanoma Research, 2008
- Impact of FDG-PET/CT Imaging on Nodal Staging for Head-And-Neck Squamous Cell CarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Inefficacy of F‐18 fluorodeoxy‐D‐glucose‐positron emission tomography scans for initial evaluation in early‐stage cutaneous melanomaCancer, 2005
- Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patientsLung Cancer, 2005
- PET imaging in oncologySeminars in Nuclear Medicine, 2000